Establishment and Clinical Application of a RPA-LFS Assay for Detection of Capsulated and Non-Capsulated Haemophilus influenzae

A recombinase polymerase amplification-lateral flow strip assay was established for detection of the outer membrane protein P6 ( ) and the capsule encoding gene of and the detection limit, sensitivity, and specificity were determined. Specific primers and probes were designed based on the published...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in cellular and infection microbiology 2022-04, Vol.12, p.878813-878813
Hauptverfasser: Wang, Yan, Liu, Aibo, Fu, Mei, Guo, Jingjing, Wang, Lei, Zuo, Xiaohua, Ma, Fenfen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A recombinase polymerase amplification-lateral flow strip assay was established for detection of the outer membrane protein P6 ( ) and the capsule encoding gene of and the detection limit, sensitivity, and specificity were determined. Specific primers and probes were designed based on the published nucleotide sequences of and . The minimum detection limit was determined with standard strains and the practical applicability of the RPA-LFS assay was assessed by detection of 209 clinical samples. The results confirmed that the RPA-LFS assay was both specific and sensitive for the detection of capsulated and non-capsulated with a detection limit of 1 CFU/µL. The detection rate of the 209 clinical samples was 97.1%, while the detection rate of capsulated was 63.2%. The detection results were consistent with the traditional culture method and dual polymerase chain reaction (PCR), confirming the applicability of the RPA-LFS assay.
ISSN:2235-2988
2235-2988
DOI:10.3389/fcimb.2022.878813